Cyclo(dehydrohistidyl-l-tryptophyl) inhibits nitric oxide production by preventing the dimerization of inducible nitric oxide synthase

Biochemical Pharmacology

Volumn 75, Issue 4, 2008, Pages 923-930

  Sohn, Mi Jin ^a   Hur, Gang Min ^b   Byun, Hee Sun ^b   Kim, Won Gon ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

BV 2 microglia; Cyclo(dehydrohistidyl l tryptophyl); Dimerization; iNOS; LPS; Nitric oxide

Indexed keywords

CYCLO(DEHYDROHISTIDYLTRYPTOPHAN); DIPEPTIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CYCLIC GMP; DIMERIZATION; ENZYME INHIBITORS; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES, CYCLIC;

EID: 38649131473     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.10.021     Document Type: Article

References (37)

1. Colasanti M., and Suzuki H. The dual personality of NO. Trends Pharmacol Sci 21 (2000) 249-252
2. Bredt D.S., and Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63 (1994) 175-195
3. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 15 (1997) 323-350
4. Gross S.S., and Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 57 (1995) 737-769
5. Griffith O.W., and Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 57 (1995) 707-736
6. Marletta M.A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78 (1994) 927-930
7. Nathan C. Inducible nitric oxide synthase: what difference does it make?. J Clin Invest 100 (1997) 2417-2423
8. Hobbs A.J., Higgs A., and Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39 (1999) 191-220
9. Eissa N.T., Yuan J.W., Haggerty C.M., Choo E.K., Palmer C.D., and Moss J. Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization. Proc Natl Acad Sci USA 955 (1988) 7625-7630
10. Chabrier P.E., Demerle-Pallardy C., and Auguet M. Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. CMLS Cell Mol Life Sci 55 (1999) 1029-1035
11. Moncada S., and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
12. Nathan C., and Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 78 (1994) 915-918
13. Konno F., and Ohtsuka M. iNOS homodimerization and a target for potential new therapeutic agents. Drugs Fut 29 (2004) 45-52
14. Stuehr D.J. Mammalian nitric oxide synthases. Biochem Biophys Acta 1411 (1999) 2146-2152
15. Albakri Q.A., and Stuehr D.J. Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability. J Biol Chem 271 (1996) 5414-5421
16. Klatt P., Pfeiffer S., List B.M., Lehner D., Glatter O., Bachinger H.P., et al. Characterization of heme-deficient neuronal nitric-oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. J Biol Chem 271 (1996) 7336-7342
17. Rodriguez-Crespo I., Gerber N.C., and Ortiz de Montellano P.R. Endothelial nitric-oxide synthase. Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation. J Biol Chem 271 (1996) 11462-11467
18. Siddhanta U., Presta A., Fan B., Wolan D., Rousseau D.L., Stuehr D.J., et al. Domain swapping in inducible nitric-oxide synthase. Electron transfer occurs between flavin and heme groups located on adjacent subunits in the dimer. J Biol Chem 273 (1998) 18950-18958
19. Sennequier N., Wolan D., and Stuehr D.J. Antifungal imidazoles block assembly of inducible NO synthase into an active dimer. J Biol Chem 272 (1999) 930-938
20. McMillan K., Adler M., and Auld D.S. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc Natl Acad Sci USA 97 (2000) 1506-1511
21. Blasko E., Glaser C.B., and Devlin J.J. Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors. J Biol Chem 277 (2002) 295-302
22. Ohtsuka M., Konno F., and Honda H. PPA250, a novel orally effective inhibitor of the dimerization of inducible nitric oxide synthase exhibits an anti-inflammatory effect in animal models of chronic arthritis. J Pharmacol Exp Ther 303 (2002) 52-57
23. Chida N., Hirasawa Y., Ohkawa T., Ishii Y., Sudo Y., Tamura K., et al. Pharmacological profile of FR260330, a novel orally active inducible nitric oxide synthase inhibitor. Eur J Pharmcol 509 (2005) 71-76
24. Davey D.D., Adler M., Arnaiz D., Eagen K., Erickson S., Guiford W., et al. Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors. J Med Chem 50 (2007) 1146-1157
25. Prasad C. Bioactive cyclic peptides. Peptides 16 (1995) 151-164
26. Mirzorva S., Koppal T., Petrova T.V., Lukas T.J., Watterson D.M., and Van Eldik L.J. Screening in a cell-based assay for inhibitors of microglial nitric oxide production reveals calmodulin-regulated protein kinases as potential drug discovery targets. Brain Res 844 (1999) 126-134
27. Song M.K., Hwang I.K., Mark J.R., Diane M.H., Dean T.Y., Ian Y., et al. Anti-hyperglycemic activity of zinc plus cyclo(his-pro) in genetically diabetic goto-kakizaki and aged rats. Exp Biol Med 228 (2003) 1338-1345
28. Song M.K., Rosenthal M.J., Hong S., Harris D.M., Hwang I., Yip I., et al. Synergistic antidiabetic activities of zinc, cyclo(his-pro), and arachidonic acid. Metabolism 50 (2001) 53-59
29. Zelenkova N.F., Vinokurova N.G., and Arinbasarov M.U. Analysis of secondary metabolites of microscopic fungi of the genus Penicillium by chromatographic techniques. Appl Biochem Microbiol 39 (2003) 52-62
30. Kim K.M., Chun S.B., Koo M.S., Choi W.J., Kim T.W., Kwon Y.G., et al. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic Biol Med 30 (2001) 747-756
31. Panda K., Rosenfeld R.J., Ghosh S., Meade A.L., Getzoff E.D., and Stuehr D.J. Distinct dimer interaction and regulation in nitric-oxide synthase types I, II, and III. J Biol Chem 277 (2002) 31020-31030
32. Bender A.T., Nakatsuka M., and Osawa Y. Heme insertion, assembly, and activation of apo-neuronal nitric-oxide synthase in vitro. J Biol Chem 275 (2000) 26018-26023
33. Klatt P., Schmidt K., Lehner D., Glatter O., Bachinger H.P., and Mayer B. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimmer. EMBO J 14 (1995) 3687-3695
34. Fukushima K., Yazawa K., and Arai T. Biological activities of albonoursin. J Antibiot 26 (1972) 175-176
35. Kimura Y., Tani K., Kojima A., Sotoma G., Okada K., and Shimada A. Cycol-(L-tryptophyl-L-phenylalanyl), a plant growth regulator produced by the fungus Penicillium sp. Phytochemistry 41 (1996) 665-669
36. Shimi I.R., and Fathey S. Isolation of cairomycins A and C. Antimicrobiol Agents Chemother 19 (1981) 941-944
37. Lucietto F.R., Milne P.J., Kilian G., Frost C.L., and Van De Venter M. The biological activity of the histidine-containing diketopiperazines cyclo(His-Ala) and cyclo(His-Gly). Peptides 27 (2006) 2706-2714